17th Annual Conference on Vaccine Research
2014 NIAID-IDSA Infectious Diseases Research Careers Meeting
24th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
16th International Symposium on Staphylococci and Staphylococcal Infections (ISSSI)
Find Practice Guidelines
The Infectious Diseases Society of America (IDSA) represents physicians, scientists and other health care professionals who specialize in infectious diseases. IDSA’s purpose is to improve the health of individuals, communities, and society by promoting excellence in patient care, education, research, public health, and prevention relating to infectious diseases.
The STAAR Act was reintroduced by Sen. Sherrod Brown this week. The bill, championed by IDSA, provides stronger federal leadership to coordinate activities that address resistance and strengthen accountability.
IDSA Applauds President’s Commitment to Combatting Antibiotic Resistance in FY 2015 Budget, Dismayed by Related Reductions
President Obama’s Fiscal Year 2015 budget includes a request to more than double funding for the CDC to combat antibiotic resistance, in addition to requests to fund efforts to track, prevent and control antibiotic resistance in the U.S. and around the world.
IDSA Applauds State of the Union Pledge on Drug Resistance
The Society reiterated its support for the Antibiotic Development to Advance Patient Treatment Act and the Strategies to Address Antimicrobial Resistance Act.
ADAPT Act Introduced to Establish New Drug Approval Pathway
IDSA applauds the bipartisan introduction of legislation to establish a new limited-population antibacterial and antifungal drug approval pathway.
IDSA Seeks Obama Admin Support for AMR Legislation
A letter sent to President Obama asks for support for current bills addressing antimicrobial resistance. Proposals include the LPAD Pathway, tax credits for research and development of drugs and diagnostics, STAAR Act, and federal funding.
Capitol Hill Briefing on Antibiotic Resistance Threats to the U.S.
IDSA, CDC, and Pew Charitable Trusts will hold a briefing on the new report from CDC on antibiotic resistant threats to the US.
IDSA Releases Core Principles for Antibacterial Drug Pathway (PDF)
IDSA and other groups outline a proposed new law to create a limited population antibacterial drug (LPAD) pathway.
Broad U.S. Response Needed to Address Pertussis (PDF)
IDSA and the Pediatric Infectious Diseases Society provided recommendations to federal health agencies to help address the rising incidence of pertussis.
1 of 8
IDSA Continues to Recommend Antivirals for Influenza
IDSA continues to recommend the use of neuraminidase inhibitor antiviral drugs in the treatment of influenza.
CUBICIN (daptomycin for injection) by Cubist Pharmaceuticals: Recall - Presence of Particulate Matter
is voluntarily recalling one lot of daptomycin for injection due to the
presence of particulate matter, identified as glass particles.
CDC Continues to Recommend Influenza Antiviral Medications
CDC continues to recommend the use of the neuraminidase inhibitor antiviral drugs as an important adjunct to influenza vaccination in the treatment of influenza.
HIV/AIDS Update - Changes to the Prezista (darunavir) label
>>Read more Using frozen stool from unrelated donors for fecal microbiota transplantation (FMT) was effective in a new pilot study in Clinical Infectious Diseases.
>> Read more
A new study in Clinical Infectious Diseases finds increased risk of stroke following shingles but suggests antiviral drugs may offer some protection.
>> Read More
In this issue:President's Message: VolunteeringCDC Reports Wide Variation in Prescribing PracticesIDSA Journal ClubPresident Requests Increased Funding on Antimicrobial ResistanceIDWeek 2014 Registration
In this issue:
>> Read More (Log-In Required)
IDSA is seeking member nominations for two Board of Director positions and Vice President.
Modifying how urine culture results are reported can improve prescribing practices, a pilot study in Clinical Infectious Diseases suggests.
New IDSA-AASLD website offers timely guidance on treatment of hepatitis C virus infection, in collaboration with IAS-USA.
People with compromised immune systems often aren’t vaccinated, but most should be, says a new practice guideline from IDSA.
1 of 7
1300 Wilson Boulevard | Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200 | Fax: (703) 299-0204
| HIVMA | Contact Us
© Copyright IDSA 2013 Infectious Diseases Society of America